首页> 外国专利> COMPOSITION CONTAINING N-ACETYLCYSTEINE IN COMBINATION WITH PROBIOTIC BACTERIA ABLE TO RESTORE THEIR OWN STOMACH BARRIER EFFECT LOST PHARMA DURING PHARMACOLOGICAL TREATMENT OF GASTRIC HYPERACIDITY

COMPOSITION CONTAINING N-ACETYLCYSTEINE IN COMBINATION WITH PROBIOTIC BACTERIA ABLE TO RESTORE THEIR OWN STOMACH BARRIER EFFECT LOST PHARMA DURING PHARMACOLOGICAL TREATMENT OF GASTRIC HYPERACIDITY

机译:包含N-乙酰水杨酸和益生菌的组合物,可在胃酸过高的药理治疗过程中恢复其自身的气孔屏障效应,可减轻失配药

摘要

FIELD: medicine, pharmacy.;SUBSTANCE: pharmaceutical composition for intestinal microflora balance restoration for subjects taking medications for reduction or treatment of gastric hyperacidity. The composition contains effective amounts of bacteria strains Lactobacillus pentosus LPS01 DSM 21980, Lactobacillus plantarum LP01 LMG P-21021, Lactobacillus rhamnosus LR06 DSM 21981 and Lactobacillus delbrueckii LDD 01 (DSMZ 20074) DSM 22106 in combination with N-acetylcysteine. Moreover, these strains are capable of colonizing the stomach at pH of from 4.0 to 5.5, and produce bacteriocins and/or metabolites, and/or hydrogen peroxide. A pharmaceutical composition cntaining effective amounts of the above bacterial strains and a drug belonging to the class of proton pump (PPI) inhibitors are also proposed. The said composition is intended to restore the intestinal microflora balance in subjects taking medications for reduction or treatment of gastric hyperacidity, dyspepsia, gastric ulcer disease and duodenal ulcer disease, gastric ulcer, gastric and duodenal ulcer, duodenal ulcer, gastritis caused by Helicobacter pylori, as well as gastroesophageal reflux disease. Food composition and food supplement with the said strains in effective amounts in combination with N-acetylcysteine are also proposed.;EFFECT: group of inventions provides ability to repair stomach own barrier effect lost during pharmacological treatment of gastric hyperacidity, and minimizes the secondary effects of such pharmacological treatment.;15 cl, 2 dwg, 6 tbl
机译:领域:药物,药学;物质:用于肠道菌群平衡恢复的药物组合物,用于服用减少或治疗胃酸过多药物的受试者。该组合物包含与N-乙酰半胱氨酸结合的有效量的细菌菌株戊糖乳杆菌LPS01 DSM 21980,植物乳杆菌LP01 LMG P-21021,鼠李糖乳杆菌LR06 DSM 21981和德氏乳杆菌LDD 01(DSMZ 20074)DSM 22106。而且,这些菌株能够在4.0至5.5的pH下定居于胃中,并产生细菌素和/或代谢产物和/或过氧化氢。还提出了包含有效量的上述细菌菌株的药物组合物和属于质子泵(PPI)抑制剂类别的药物。所述组合物旨在恢复服用减少或治疗胃酸过多,消化不良,胃溃疡病和十二指肠溃疡病,胃溃疡,胃和十二指肠溃疡,十二指肠溃疡,幽门螺杆菌引起的胃炎的药物的受试者的肠道菌群平衡。以及胃食管反流病。还提出了以有效量的所述菌株与N-乙酰半胱氨酸组合的食物组合物和食物补充剂。效果:一组发明提供了修复在胃酸过多的药理学治疗过程中失去的胃自身屏障作用的能力,并最大程度地降低了胃酸过多的次级作用。 15 cl,2 dwg,6 tbl

著录项

  • 公开/公告号RU2617952C2

    专利类型

  • 公开/公告日2017-04-28

    原文格式PDF

  • 申请/专利权人 MOGNA GIOVANNI;

    申请/专利号RU20140107770

  • 发明设计人 MOGNA GIOVANNI (IT);

    申请日2012-09-10

  • 分类号A61K35/741;A61K35/747;A61K31/198;A23L33/135;A61P1/04;

  • 国家 RU

  • 入库时间 2022-08-21 13:23:36

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号